Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

Conditions:   Head and Neck Squamous Cell Carcinoma;   Cutaneous Squamous Cell Carcinoma;   Head and Neck Cancer;   Head and Neck Carcinoma
Interventions:   Drug: Lenvatinib Pill;   Drug: Cetuximab
Sponsor:   Memorial Sloan Kettering Cancer Center
Recruiting

https://ift.tt/2IBBtQ7